Cybin CEO AMA: Patents, DMT Trials, Timelines and Raising Capital in a Recession | CYBN Stock

Drugmakers gear up for joint IRA arguments as PhRMA appeals Texas verdict

Legal experts anticipate a “full range” of constitutional and statutory arguments from drugmakers that are jointly set to have their cases heard against the Inflation

March 7, 2024

Proactively screening diabetes patients for heart disease does not improve long-term survival

While coronary heart disease and diabetes are often seen in the same patients, a diagnosis of diabetes does not necessarily mean that patients also have

November 18, 2024

Neurocrine wins approval of Ingrezza ‘sprinkle’ formulation for patients with trouble swallowing

Neurocrine Biosciences won FDA approval on Tuesday for a new formulation that may help Ingrezza go down in a more delightful way. The oral granules

May 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.